title: Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice.
authors.forename: P E
authors.initials: PE
authors.lastname: Lipsky
authors.forename: S B
authors.initials: SB
authors.lastname: Abramson
authors.forename: F C
authors.initials: FC
authors.lastname: Breedveld
authors.forename: P
authors.initials: P
authors.lastname: Brook
authors.forename: R
authors.initials: R
authors.lastname: Burmester
authors.forename: F
authors.initials: F
authors.lastname: Buttgereit
authors.forename: G W
authors.initials: GW
authors.lastname: Cannon
authors.forename: F
authors.initials: F
authors.lastname: Catella-Lawson
authors.forename: L J
authors.initials: LJ
authors.lastname: Crofford
authors.forename: M
authors.initials: M
authors.lastname: Doherty
authors.forename: M
authors.initials: M
authors.lastname: Dougados
authors.forename: R N
authors.initials: RN
authors.lastname: DuBois
authors.forename: J
authors.initials: J
authors.lastname: Froelich
authors.forename: L A
authors.initials: LA
authors.lastname: Garcia Rodriguez
authors.forename: A
authors.initials: A
authors.lastname: Gibofsky
authors.forename: S
authors.initials: S
authors.lastname: Hernandez-Diaz
authors.forename: M C
authors.initials: MC
authors.lastname: Hochberg
authors.forename: A
authors.initials: A
authors.lastname: Krause
authors.forename: M H
authors.initials: MH
authors.lastname: Liang
authors.forename: K
authors.initials: K
authors.lastname: Machold
authors.forename: P M
authors.initials: PM
authors.lastname: Peloso
authors.forename: L G
authors.initials: LG
authors.lastname: Raisz
authors.forename: B
authors.initials: B
authors.lastname: Schayes
authors.forename: J M
authors.initials: JM
authors.lastname: Scheiman
authors.forename: L S
authors.initials: LS
authors.lastname: Simon
authors.forename: J
authors.initials: J
authors.lastname: Smolen
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D051546:Cyclooxygenase 2; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D008565:Membrane Proteins; D010146:Pain / Q000188:drug therapy*; D011451:Prostaglandin-Endoperoxide Synthases / Q000494:pharmacology*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004791:Enzyme Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases